Drugs in Dev.
Dermatology
Phase II
New Zealand 
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Sirolimus
Therapeutic Area : Dermatology
Study Phase : Phase II
Sponsor : Timber Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Details : Extension of agreement with AFT Pharmaceuticals grants Desitin Arzneimittel GmbH exclusive license and supply rights for TMB-002 in Europe.
Product Name : Pascomer
Product Type : Antibiotic
Upfront Cash : Undisclosed
March 17, 2021
Lead Product(s) : Sirolimus
Therapeutic Area : Dermatology
Highest Development Status : Phase II
Sponsor : Timber Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Licensing Agreement
